CEN Biotech, Inc. CENBF
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -234.56% | -410.46% | -- | -- | -- |
| Total Depreciation and Amortization | -7.02% | -13.58% | -- | -- | -- |
| Total Amortization of Deferred Charges | -66.43% | -50.92% | -- | -- | -- |
| Total Other Non-Cash Items | 140.39% | 149.03% | -- | -- | -- |
| Change in Net Operating Assets | -94.45% | -87.42% | -- | -- | -- |
| Cash from Operations | -199.24% | -28.54% | -- | -- | -- |
| Capital Expenditure | 77.89% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | 210.90% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.64% | -494.41% | -- | -- | -- |
| Cash from Investing | -242.71% | 151.94% | -- | -- | -- |
| Total Debt Issued | -42.97% | -73.86% | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 51.39% | -5.55% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 159.38% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.60% | 9,404.00% | -- | -- | -- |